Advanced Gene Therapy for Duchenne Muscular Dystrophy Treatment Abroad

Advanced gene therapy for Duchenne muscular dystrophy is transforming the treatment approach for children affected by this rare neuromuscular disorder. DMD is caused by genetic mutations that weaken muscles over time and affect mobility, breathing, and overall physical function. Modern gene therapy aims to target these mutations and improve muscle strength through innovative medical solutions. Exon skipping therapy and other genetic treatments are increasingly used to manage Duchenne muscular dystrophy symptoms and slow disease progression. International patients often travel abroad to access specialized neurology hospitals equipped with advanced medical technology and experienced muscular dystrophy specialists. These healthcare facilities focus on personalized treatment plans designed according to each patient’s condition.